Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research
14 août 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Lyme disease diagnostics market is expected to total US$ 1.56 billion in 2023...
Bay Area Lyme Foundation Celebrates Its 10th Anniversary with a Convergence of Scientists, Clinicians, Patients and Celebrity Talent
13 juin 2023 11h00 HE
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, celebrated its 10th anniversary in May at LymeAid®, its...
Bay Area Lyme Foundation Celebrates Department of Defense CDMRP Tick-borne Disease Awardees
23 mars 2023 11h00 HE
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have...
National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme Foundation
09 mars 2023 11h00 HE
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces it has awarded more than $1M to the University of...
Bay Area Lyme Foundation Researcher Validates New Approach to Overcome Challenges of Lyme Disease Diagnosis in the Lab
06 févr. 2023 11h00 HE
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a laboratory study published in...
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease
15 déc. 2022 08h30 HE
|
Tarsus Pharmaceuticals, Inc
Positive Phase 1b Callisto data shows that TP-05 is well tolerated and safety data supports progression to Phase 2a Phase 2a Carpo trial to evaluate the safety, tolerability, and proof-of-activity of...
With Expanded Outdoor Features, Lifestyle Healing Institute Integrates Traditional and Holistic Medicine
29 août 2022 08h04 HE
|
Lifestyle Healing Institute
NAPLES, Fla., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Lifestyle Healing Institute, a center for complementary and alternative medicine, treats illnesses with data-driven approaches delivered by a medical...
Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
15 juin 2022 07h30 HE
|
Adaptive Biotechnologies
SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
RightEye Enters Into Agreement With MIT to Research Ocular Biomarker 'Signature' for Lyme Disease
25 avr. 2022 11h15 HE
|
RightEye LLC
BETHESDA, Md., April 25, 2022 (GLOBE NEWSWIRE) -- RightEye, the world's leading eye-tracking biomarker company, has signed a research collaboration agreement with the Massachusetts Institute of...
Evidence of Manipulated Lyme Disease Diagnostics Presented to Suffolk County, NY Health Commissioner
11 mars 2022 08h00 HE
|
TruthCures
GREAT RIVER, N.Y., March 11, 2022 (GLOBE NEWSWIRE) -- Nonprofit grassroots organization TruthCures, Inc. held a virtual meeting with Suffolk County, NY Health Commissioner Gregson Pigott, MD, MPH,...